<DOC>
	<DOCNO>NCT02720211</DOCNO>
	<brief_summary>Nearly migraine sufferer report sensitivity light headache significant proportion sufferer report light sensitivity attack . Light also common trigger migraine headache . Spectacle lenses treated tint spectacle lens treat thin-films show reduce light sensitivity headache patient migraine . At time , clear spectacle lens treatment superior . The purpose trial determine 's significant , therapeutic advantage either spectacle lens treatment . Both treatment could novel , non-invasive adjuvant treatment migraine .</brief_summary>
	<brief_title>Spectacle Tints Thin-Films Migraine</brief_title>
	<detailed_description>Approximately 6 % men 18 % woman afflict migraine . ( Stovner et al. , 2006 ) Over 90 % patient migraines report sensitivity light ( photophobia ) headache . ( Evans et al. , 2008 ) Some migraine sufferer report light trigger migraine chronic sensitivity light ( Main et al. , 1997 ) . Migraineurs especially sensitive non-incandescent lighting source fluorescent light , computer monitor , gas-vapor lamp ( Katz Digre , 2016 ) . The pathway mediate photophobia appear involve intrinsically photosensitive retinal ganglion cell ( `` IPRGCs '' ; Hattar et al. , 2002 ) trigeminal afferent ( Noseda et al. , 2010 ; Digre Brennan , 2012 ) . These retinal cell require input photoreceptors activate light , show responsible circadian rhythm entrainment pupillary light reflex . As , cell constitute pathway separate visual pathway ( GÃ¼ler et al. , 2008 ) . IPRGCs contain chromophore melanopsin . In cell , 480 nm light ( blue-green portion visible spectrum ) isomerize melanopsin trigger phototransduction cascade . However , IPRGCs also stimulate rod cone . Thus , IPRGCs stimulate directly 480-nm light indirectly light visible spectrum . In present study , investigator use neutral gray tint decrease stimulation eye wavelength visible spectrum . The investigator compare intervention thin-film spectacle coating design specifically block 480-nm light . The gray tint decrease direct indirect stimulation IPRGCs block wavelength visible spectrum . The 480-nm thin-film specifically target direct stimulation IPRGC . All tint thin film calibrate optical density , overall `` darkness '' study lenses , . All study lenses appear overall light block effect study subject . The lens intend preventative prophylactic treatment chronic migraine .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Subjects must meet International Headache Society criterion chronic migraine ( International Classification Headache Disorders , 3rd edition ( Headache Classification Committee International Headache Society , 2013 ) . All subject must age 18 60 yearsold . To include study , best judgment investigator , subject must stable current migraine treatment regimen . Stability define major change therapy contemplate within next 4 month . Subjects light sensitive condition , iritis blepharospasm , exclude . Subjects bestcorrected visual acuity le 20/40 exclude . Subjects diseases retina , diabetic retinopathy macular degeneration exclude . Subjects use medication know affect eye exclude ( e.g . chloroquine , hydroxychloroquine , ethambutol , amiodarone ) . Due constraint manufacture mount study lens study frame , study must exclude subject nearsighted ( 4 diopter ) , subject farsighted ( 2 diopter ) , subject 2.5 diopter astigmatism . Because cyclical effect botulinum toxin injection nerve block , patient undergo treatment exclude . Subjects must injections block within 4 month enrollment receive block exit study . Subjects continuous daily headache ( headache frequency 100 % ) exclude . Subjects headache frequency least 50 % exclude . Subjects medication overuse headache exclude . A patient history medication overuse overused abortive medication past 4 month include . Subjects abuse alcohol use illicit drug exclude . Subjects consider vulnerable population exclude , include pregnant woman , prisoner , subject mentally disabled , subject cognitive decisional impairment , ward state</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>headache</keyword>
	<keyword>photophobia</keyword>
	<keyword>migraine</keyword>
	<keyword>light sensitivity</keyword>
	<keyword>tint</keyword>
	<keyword>thin film</keyword>
</DOC>